Should patients with hepatitis C genotype 2/3 infection who are slow responders to pegylated interferon/ribavirin have treatment duration extended?

Carla Silva, Elizabeth Ianna, Tracey Jones, Joshua Davis

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Should patients with hepatitis C genotype 2/3 infection who are slow responders to pegylated interferon/ribavirin have treatment duration extended?'. Together they form a unique fingerprint.

Medicine and Dentistry